Emami Ltd
NSE: EMAMILTD BSE: 531162FMCG
Emami is engaged in manufacturing & marketing of personal care & healthcare products with an enviable portfolio of household brand names such as BoroPlus, Navratna, Fair and Handsome, Zandu Balm, Kesh King, Zandu Pancharishta, Mentho Plus Balm and others.(Source : 201903 Annual Report Page No: 193)
₹420
52W: ₹385 — ₹655
PE 20.9 · Book ₹71.8 · +485% vs bookMarket Cap₹18,313 Cr
Stock P/E20.9Price to Earnings
ROCE34%Return on Capital
ROE31.5%Return on Equity
Div. Yield2.39%Face Value ₹1
Strengths
- +Company has reduced debt.
- +Company is almost debt free.
- +Company has a good return on equity (ROE) track record: 3 Years ROE 29.1%
- +Company has been maintaining a healthy dividend payout of 54.2%
Weaknesses
- −The company has delivered a poor sales growth of 5.50% over past five years.
- −Tax rate seems low
Shareholding Pattern
Promoters54.84%
FIIs8.57%
DIIs26.91%
Public9.67%
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 54.84% | 54.84% | 54.84% | 54.84% | 54.84% | 54.84% | 54.84% | 54.84% |
| FIIs | 14.02% | 14.38%▲0.4 | 14.11%▼0.3 | 12.11%▼2.0 | 11.89%▼0.2 | 10.93%▼1.0 | 9.03%▼1.9 | 8.57%▼0.5 |
| DIIs | 21.61% | 21.51%▼0.1 | 21.7%▲0.2 | 23.68%▲2.0 | 24.06%▲0.4 | 25%▲0.9 | 26.72%▲1.7 | 26.91%▲0.2 |
| Public | 9.53% | 9.27%▼0.3 | 9.36%▲0.1 | 9.38%▲0.0 | 9.21%▼0.2 | 9.22%▲0.0 | 9.4%▲0.2 | 9.67%▲0.3 |
Financial Statements
| Metric | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 701 | 813 | 709 | 755 | 709 | 879 | 781 | 756 | 604 | 958 |
| Expenses | 494 | 530 | 521 | 564 | 483 | 550 | 590 | 556 | 437 | 572 |
| Operating Profit | 207 | 283 | 188 | 192 | 226 | 328 | 191 | 201 | 168 | 385 |
| OPM % | 30% | 35% | 27% | 25% | 32% | 37% | 24% | 27% | 28% | 40% |
| Net Profit | 164 | 249 | 152 | 176 | 214 | 279 | 190 | 163 | 182 | 330 |
| EPS ₹ | 3.75 | 5.71 | 3.48 | 4.03 | 4.9 | 6.4 | 4.35 | 3.74 | 4.18 | 7.56 |
AI Insights
Revenue Trend
TTM revenue at ₹3,099Cr, down 0.8% YoY. OPM at 30%.
Debt Position
Borrowings at ₹16Cr. Debt-to-equity ratio: 0.01x. Healthy balance sheet.
Capex Cycle
CWIP at ₹16Cr (2% of fixed assets). Moderate ongoing capital expenditure.
Institutional Flow
DIIs: 26.91% (+0.69pp change). FIIs: 8.57% (-2.89pp change). Promoters hold 54.84%.
Margin & Efficiency
ROCE declining from 51% (Mar 2014) to 34% (Mar 2025). Working capital days: 37.
Valuation
PE 20.9x with 34% ROCE. Price is 485% above book value of ₹71.8. Dividend yield: 2.39%.
Recent Announcements
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 14 May - Post declaration of Q4 FY26 Financial Results, the Company will hold a Conference Call with Analysts / Investors on Thursday, 21st May, 2026 at 4:00 …
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 13 May - Senior management to attend 360 ONE Capital Investor Conference in Mumbai on 28 May 2026.
- Announcement under Regulation 30 (LODR)-Updates on Acquisition 7 May - Emami executed a share subscription and purchase agreement to acquire stake in IncNut Digital Private Limited.
- Announcement under Regulation 30 (LODR)-Press Release / Media Release 7 May - Emami acquires 60% of IncNut Digital for Rs321 crore, expanding into personalised BPC via Vedix and SkinKraft.
- Announcement under Regulation 30 (LODR)-Acquisition 7 May - Board approves acquiring 60% stake in IncNut Digital for up to Rs 321 crore on May 7, 2026.
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Financial Year 2023 from bse